| 000 | 01870 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516092408.0 | ||
| 264 | 0 | _c20120619 | |
| 008 | 201206s 0 0 jpn d | ||
| 022 | _a0385-0684 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakashima, Toshihisa | |
| 245 | 0 | 0 |
_a[A case of neurotoxicity reduced with pregabalin in R-CHOP chemotherapy for diffuse large B-cell lymphoma]. _h[electronic resource] |
| 260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cMay 2012 |
||
| 300 |
_a809-12 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xprevention & control |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 | _aPregabalin |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 |
_aVincristine _xadverse effects |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xanalogs & derivatives |
| 700 | 1 | _aKiba, Takayoshi | |
| 700 | 1 | _aOgawa, Yoshikazu | |
| 700 | 1 | _aKimura, Akiko | |
| 700 | 1 | _aKido, Miki | |
| 700 | 1 | _aOkikawa, Yoshiko | |
| 700 | 1 | _aIto, Takuo | |
| 700 | 1 | _aSaito, Akihisa | |
| 700 | 1 | _aHosokawa, Atsuko | |
| 700 | 1 | _aShintani, Hiromi | |
| 700 | 1 | _aOkada, Yuko | |
| 700 | 1 | _aTaniguchi, Takako | |
| 700 | 1 | _aTaniyama, Kiyomi | |
| 700 | 1 | _aKozawa, Kazuhiro | |
| 700 | 1 | _aNiimi, Hiromasa | |
| 773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 39 _gno. 5 _gp. 809-12 |
|
| 999 |
_c21779874 _d21779874 |
||